| Name | Title | Contact Details |
|---|
BMW of Buena Park is one of the largest and most popular BMW dealerships in the Buena Park area. Our dealership features an extensive inventory of new and pre-owned BMW vehicles for sale, exclusive BMW lease specials and financing offers, a state-of-the-art service center, and an experienced team of BMW enthusiasts ready to assist you with any request you may have.
Placing small E&S risks shouldnt be hard. Pathpoint was built to make it faster and easier for retail agents to get great E&S coverage options. Quote and bind coverage for your small business clients online with one streamlined submission. Receive multiple bindable quotes for your clients in minutes, not days.
Hoja is a business center dedicated in offering a bundle of services to businesses and individuals. Our offices are located in the capital city of Kosova in Prishtina. We aim to build and offer a bundle of services to businesses and individuals by delivering value and high quality solutions. Our commitment ranges from the beginning of a collaboration, to the extensive needs that follow through our partnerships. We must provide value, both for our company and our clients. We must meet or exceed all requirements in an efficient and cost effective manner. We must maintain a balance of proven techniques with the ability to be innovative . Our markets will include industrial, commercial, agricultural, regional and residential clients. Our company will be able to provide a package of services that will allow us to offer conception to completion efficiency.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.